Bukwang Pharmaceutical Co., Ltd.
003000.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
120
Cost of Revenue
64
Gross Profit
56
Gross Margin
46.4%
Operating Income
1
Operating Margin
1.0%
Net Income
-2
Net Margin
-1.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
6
EBITDA Margin
4.8%
2023
12/31/2023
Revenue
94
Cost of Revenue
57
Gross Profit
38
Gross Margin
39.7%
Operating Income
-28
Operating Margin
-29.8%
Net Income
-23
Net Margin
-24.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-24
EBITDA Margin
-25.0%
2022
12/31/2022
Revenue
143
Cost of Revenue
84
Gross Profit
60
Gross Margin
41.6%
Operating Income
-0
Operating Margin
-0.1%
Net Income
-2
Net Margin
-1.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
4
EBITDA Margin
3.0%
2021
12/31/2021
Revenue
137
Cost of Revenue
80
Gross Profit
57
Gross Margin
41.5%
Operating Income
4
Operating Margin
3.1%
Net Income
-1
Net Margin
-0.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
9
EBITDA Margin
6.2%
2020
12/31/2020
Revenue
127
Cost of Revenue
74
Gross Profit
54
Gross Margin
42.2%
Operating Income
3
Operating Margin
2.4%
Net Income
-5
Net Margin
-4.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2
EBITDA Margin
1.3%